About this trial
To construct a prediction model of progesterone sensitivity in patients with endometrial cancer treated with fertility preservation
Eligibility criteria
Qualifiers
Have a confirmed pathological diagnosis based upon hysteroscopy: atypical endometrial hyperplasia or histologically prove well-differentiated EEC G1 without myometrial invasion
No signs of suspicious extrauterine involvement on enhanced magnetic resonance imaging (MRI) or enhanced computed tomography (CT) or ultrasound
Have a desire for remaining reproductive function or uterus
Good compliance with adjunctive treatment and follow-up
Disqualifiers
Acute liver disease or liver tumor (benign or malignant) or renal dysfunction
Pregnancy or potential pregnancy
Confirmed diagnosis of any cancer in reproductive system
Acute severe disease such as stroke or heart infarction or a history of thrombosis disease
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
Sponsors and collaborators
Peking University People's Hospital
Lead sponsor
Peking University
Collaborator
Beihang University
Collaborator